Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$128.58M+76.5%-$546.38M-8.0%-$506.01M+4.3%-$528.73M+19.9%-$660.12M-111%
$10.06M-22.6%$12.99M-0.8%$13.09M-11.7%$14.83M-5.4%$15.67M+13.7%
$36.93M-11.4%$41.67M-13.4%$48.11M-13.1%$55.39M-8.8%$60.71M-14.5%
-$111.84M-0.6%-$111.21M+9.4%-$122.79M+17.9%-$149.55M+14.3%-$174.43M+15.3%
$4.45M+59.1%$2.8M-21.3%$3.56M
$106.07M-8.1%$115.45M-21.8%$147.66M-2.7%$151.82M-25.3%$203.37M+64.0%
-$47.58M-10.7%
-$2.87M-137%$7.67M+135%-$21.91M+51.5%-$45.16M
-$116.21M-2.0%-$113.92M+9.8%-$126.26M+17.1%-$152.32M+14.5%-$178.13M+16.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pacific Biosciences of California generate?
Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
What is Pacific Biosciences of California's free cash flow?
After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
Where does Pacific Biosciences of California's cash flow data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.